[1]
Korga, A. et al. 2019. Evaluation of the combined effects of doxorubicin and bortezomib on the human acute lymphoblastic leukemia cell line. Current Issues in Pharmacy and Medical Sciences. 32, 2 (Jun. 2019), 87–91. DOI:https://doi.org/10.2478/cipms-2019-0017.